Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Novartis

www.novartis.com

Forum 1
Novartis Campus
Basel
CH-4056
Switzerland

+41 61 324 11 11

Activities

Training & Education | Manufacturing | Drug Delivery | Research & Development | Pharmaceutical

Related Companies

  • Lonza
  • Hermes Pharma GmbH
  • GEA Pharma and Healthcare
  • Titan Enterprises
  • Actylis – The Partner of Choice
  • ProtaGene
  • Qualicaps
  • Austar
  • Asynt
  • LB Bohle
  • Vetter Pharma International
  • Starlab
  • Gerresheimer
  • Romaco Holding GmbH
  • Vectorbuilder Inc
  • Innopharma Technology
  • Butterworth Laboratories
  • DWK Life Sciences
  • Indena
  • Nanoform

Related Content

Intellegens secures $2m to support research of oligonucleotide therapeutic manufacture
Intellegens secures $2m to support research of oligonucleotide therapeutic manufacture
Unither Pharmaceuticals acquires Novartis' Brazilian manufacturing facility
Unither Pharmaceuticals acquires Novartis' Brazilian manufacturing facility
Novartis completes acquisition of precision medicine developer Chinook
Novartis completes acquisition of precision medicine developer Chinook
MIT researchers to lead a new centre for continuous mRNA manufacturing
MIT researchers to lead a new centre for continuous mRNA manufacturing
Novartis publishes data on multiple sclerosis treatment
Novartis publishes data on multiple sclerosis treatment
Made in Switzerland: blockchain enabled healthcare
Made in Switzerland: blockchain enabled healthcare
Sterling acquires API manufacturing facility
Sterling acquires API manufacturing facility
Therapeutic: iptacopan for paroxysmal nocturnal haemoglobinuria
Therapeutic: iptacopan for paroxysmal nocturnal haemoglobinuria
Novartis and MMV move to Phase III study to treat uncomplicated malaria
Novartis and MMV move to Phase III study to treat uncomplicated malaria
Therapeutic: tislelizumab for oncology
Therapeutic: tislelizumab for oncology
Therapeutic: leniolisib for APDS
Therapeutic: leniolisib for APDS
Sterling Pharma Solutions acquires Novartis Facility in Ireland
Sterling Pharma Solutions acquires Novartis Facility in Ireland
Therapeutic: inclisiran for hypercholesterolaemia
Therapeutic: inclisiran for hypercholesterolaemia
Novartis to fund protein degrader therapy research
Novartis to fund protein degrader therapy research
Therapeutics: osilodrostat for Cushing’s disease
Therapeutics: osilodrostat for Cushing’s disease
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company